Your browser doesn't support javascript.
loading
The histone deacetylase inhibitor chidamide improve the sensitivity of chronic myelogenous leukemia drug-resistant cells to imatinib by regulating PTPN6.
Lu, Yaqiong; Sun, Li; Yang, Lin; Liu, Xiaojun; Liu, Menghan; Zhang, Xiaoyan; Nie, Ziyuan; Pan, Yuxia; Wang, Xingzhe; Luo, Jianmin.
  • Lu Y; Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Sun L; Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Yang L; Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Liu X; Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Liu M; Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Zhang X; Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Nie Z; Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Pan Y; Key Laboratory of Hematology, Shijiazhuang, China.
  • Wang X; Key Laboratory of Hematology, Shijiazhuang, China.
  • Luo J; Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China - luojm3155@163.com.
Minerva Med ; 2023 May 17.
Article en En | MEDLINE | ID: mdl-37198889
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Año: 2023 Tipo del documento: Article